[EMAIL PROTECTED] writes:


>Sue Hartigan <[EMAIL PROTECTED]> writes:

>WASHINGTON--The scientific process
>has given birth to many medical miracles
>over the years. But sometimes it can be a cruel
>parent. 
>As a result of a New York Times story Sunday trumpeting news
>that two chemicals discovered by a Boston researcher can cure
>cancer in mice, oncologists across the country have been
>overwhelmed by patients seeking this remarkable new therapy. 

[-]
>Scientists themselves question the process. 
>"It's really too bad that we make these sorts of announcements,"
>McGinnis said. "It's great for the public in general, great for the
>stock market--but for the cancer patient with only six months to
>live, it's unbelievably cruel." 
>Cimons reported from Washington, Getlin from New York and
>Maugh from Los Angeles. 

Gee whiz.  Don't these lying, ignorant idiots know like Mac and Bill that
"leaders in this field" have found that we have a breakthrough?

>* INVESTOR FRENZY: Techniclone stock surged on its
>report of new drug findings. D2 
>Los Angeles Times 

Hmm savvy stock investors couldn't be wrong could they?

[extractinons from the article]
>In New York, several publishing houses confirmed Tuesday that
>they had received copies of a book proposal about the alleged
>cancer cure from John Brockman, an agent representing Gina
>Kolata, who wrote Sunday's story.

>"I don't have a problem with it," said the publishing official. "But
>[some people might] in this day of public wailing over media ethics."

>News organizations generally try to avoid such situations to
>avoid the appearance of a conflict of interest. Critics charge that
>reporters cannot function as honest brokers of information on a
>story when they have simultaneously contracted to write a book
>about their sources.

Seems to have a bad smell to me.  Guess not hereabouts.

Thanks, Sue.
Best,     Terry 

"Lawyer - one trained to circumvent the law"  - The Devil's Dictionary 



Subscribe/Unsubscribe, email: [EMAIL PROTECTED]
In the body of the message enter: subscribe/unsubscribe law-issues

Reply via email to